CURX offering history
Every offering-related filing in Curanex Pharmaceuticals Inc’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 65 filings back to Jun 20, 2024.
| Date | Filing | What it means | |
|---|---|---|---|
| Sep 29, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 26, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 26, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 12, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 22, 2025 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jul 18, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jul 10, 2025 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jul 1, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Mar 19, 2025 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Mar 17, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 14, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Nov 27, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Nov 1, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Oct 16, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
CURX offering FAQ
When did CURX last execute an offering?
Per SEC filings, Curanex Pharmaceuticals Inc's most recent priced offering document is a 8-K filed 2025-09-29. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did CURX last announce or register an offering?
The most recent registration is a S-1/A filed 2025-07-18. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.
Free to use. No account, no card.